Efficacy and Safety of Medtronic 780G Automated Insulin Delivery System in Adults With Type 1 Diabetes and Gastroparesis
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
The goal of this clinical trial is to evaluate the efficacy and safety of Medtronic 780G automated insulin delivery system in adult persons with type 1 diabetes and gastroparesis.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age ≥18 years
• Diagnosis of T1D for at least 12 months with stable insulin regimen for at least 2 months
• HbA1c ≥8.0%
• Diagnosis of gastroparesis per National Institute of Health (NIH) definition
• Willing to use Medtronic 780G system either with Simplera CGM.
• Ability to provide informed consent before any trial-related activities
• If randomized to usual care group and on an insulin pump already, should be willing to use pump in manual mode only for the duration of the study
Locations
United States
Indiana
Indiana University Health, Univeristy hospital
RECRUITING
Indianapolis
Contact Information
Primary
Sana Kalaji
skalaji@iu.edu
317-278-6017
Time Frame
Start Date: 2026-02-09
Estimated Completion Date: 2026-12-01
Participants
Target number of participants: 34
Treatments
Experimental: Medtronic 780G group
No_intervention: Usual care
Participants will continue either multiple daily injections or non-AID insulin pumps
Related Therapeutic Areas
Sponsors
Collaborators: Medtronic
Leads: Viral N. Shah